Vital SignsVital SignsCheck your MP →
PCUAmy Rylance — no licensed photograph is available, so the sector leader plate is shown instead.

Sector leader

Amy Rylance

Director of Health Services, Equity & Improvement, Prostate Cancer UK

Prostate Cancer UK is based in Bermondsey and Old Southwark (London) — the organisation’s base, not a personal address.

Press citations

4

Topics

2

Hospital discharge / bed-blocking

Last quoted

Aug 2026

Amy Rylance: key facts

Kind of voice
Sector leader
Role
Director of Health Services, Equity & Improvement
Organisation
Prostate Cancer UK
Organisation based in
Bermondsey and Old Southwark
Quoted on
Hospital discharge / bed-blocking, Cancer
Tracked press citations
4
Most recently quoted
27 Aug 2026

Who Amy Rylance is

Amy Rylance is Director of Health Services, Equity & Improvement at Prostate Cancer UK, the UK's largest men's health charity, headquartered at The Counting House, 53 Tooley Street, London. She began her career working with people with learning disabilities and mental health issues, before taking a role across Bradford District focused on reducing health inequalities, where she established social prescribing in primary care and a supported hospital discharge service. She subsequently joined Diabetes UK as Head of Healthcare Engagement and Development, working nationally on clinical education and service improvement, before joining Prostate Cancer UK in 2019. At Prostate Cancer UK she has led clinical-skills education programmes, co-authored journal pieces on the evidence base, and led the charity's risk awareness work since 2021, including a joint campaign with the NHS through which over 4 million men have completed the online risk checker. She is publicly known for arguing that NHS primary care guidelines preventing GPs from proactively discussing prostate cancer risk are outdated and that persistent health inequalities for Black men — who are twice as likely to be diagnosed and twice as likely to die from the disease — demand urgent policy action.

“Darolutamide is an important new treatment that gives thousands of men with incurable prostate cancer another effective option that could halve their risk of death.”

References for this biography

  1. 1.Amy Rylance | Prostate Cancer UK (staff profile) — Career background, role at Prostate Cancer UK, Clinical Champions programme, risk checker achievement, health inequity focus
  2. 2.Men missing out on targeted treatments that have fewer side effects | Prostate Cancer UK — Confirms current title as Director of Health Services, Equity & Improvement (2026)
  3. 3.Closing the gap: our response to the recommendations on prostate cancer screening | Prostate Cancer UK — Confirms current title; establishes her public position on UKNSC screening recommendations and Black men's health inequalities (February 2026)
  4. 4.Prostate Cancer UK and Prostate Cancer Research join forces to launch parliamentary group | Prostate Cancer UK — Quoted on outdated NHS guidelines and health inequalities for Black men; involvement in APPG launch (January 2025)
  5. 5.Every cancer patient in the UK to get their own Personalised Cancer Plan | Open Access Government — Press quote confirming title Director of Health Services, Equity & Improvement; advocacy for personalised cancer plans (February 2026)
  6. 6.Government can save lives and smash inequalities by changing prostate cancer guidelines, say experts | University of Manchester — Press coverage of Rylance's public arguments on NHS guidelines and late diagnosis disproportionately affecting Black men and deprived communities
  7. 7.Prostate Cancer UK – Companies House — Confirms registered office address: The Counting House, Fourth Floor, 53 Tooley Street, London SE1 2QN

Notable achievements

  • Led Prostate Cancer UK's risk awareness work since 2021, including a joint campaign with the NHS, resulting in over 4 million men completing the charity's online risk checker. Source ↗
  • Established Prostate Cancer UK's flagship Clinical Champions clinical leadership education programme and co-authored multiple journal pieces that the charity states significantly shifted the evidence base. Source ↗
  • Represented Prostate Cancer UK at the launch of the All-Party Parliamentary Group on Prostate Cancer (January 2025), co-founded with Prostate Cancer Research, calling for equitable early diagnosis and reform of outdated NHS guidelines. Source ↗
  • Publicly responded on behalf of Prostate Cancer UK to the UK National Screening Committee's 2026 draft recommendation on prostate cancer screening, calling for evidence gaps on Black men to be closed as a priority. Source ↗

What Amy Rylance has said

Where Amy Rylance has been quoted

  1. Prostate cancer drug that can halve death risk to be offered to thousands in Englandtheguardian.com · 27 Aug 2026
  2. NHS expands access to prostate cancer drug in England to save thousands of livestheguardian.com · 27 Aug 2026
  3. Most UK men should not be offered prostate cancer screening, experts saytheguardian.com · 27 Aug 2026
  4. ‘I’ve been living under a shadow for 13 years’: life with prostate cancertheguardian.com · 27 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Contact & links

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.